Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heera Chemicals is an Indian pharmaceutical company specializing in the manufacture and export of Active Pharmaceutical Ingredients (APIs) and bulk drug intermediates. Established in 1993 and headquartered in Mumbai, the company focuses primarily on the therapeutic area of diabetes, producing high-quality generic APIs such as Metformin, Gliclazide, and various Gliptins. Heera Chemicals operates state-of-the-art manufacturing facilities that comply with international quality standards, serving both domestic and global markets. Their portfolio also extends to anti-hypertensive and other chronic disease medications, positioning them as a key supplier in the generic pharmaceutical supply chain. The company is recognized for its commitment to quality and cost-effective manufacturing solutions for the global healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heera Chemicals.